We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000860:SSEBeijing Shunxin Agriculture Co.,Ltd Analysis

Data as of 2026-05-29 - not real-time

₩13,320.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Kangnam Jevisco is trading at 13,320 KRW, well below its 20‑day (15,154 KRW), 50‑day (15,038 KRW) and 200‑day (13,932 KRW) moving averages, indicating a price weakness despite the model’s bullish trend flag. The RSI of 33.5 points to oversold conditions, yet the MACD remains firmly bearish (line –415 vs signal –196) and the histogram is negative, suggesting continued downside momentum. Fundamentally the company is struggling: revenue growth is modest at 4.2%, profit margin is –0.66%, and both ROE (–0.07%) and free cash flow (‑8.15 B KRW) are negative. Debt is high (Debt‑to‑Equity ≈ 19) and cash barely covers liabilities, raising concerns about dividend sustainability despite a 1.81% yield. The DCF‑derived fair value of ~31,170 KRW is more than double the current price, implying potential upside if the firm can reverse its earnings trajectory. Volatility is elevated at ~50% over 30 days, though beta is low (0.37), indicating market‑wide swings are muted but the stock itself is prone to large moves.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Price is near the technical support level (13,210 KRW)
  • Bearish MACD and negative histogram
  • High debt load and negative earnings

Medium Term

1–3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained negative profit margins and free cash flow
  • Elevated volatility with limited upside potential
  • Dividend may be cut due to earnings weakness

Long Term

> 3 years
Positive
Model confidence: 4/10

Key Factors

  • DCF fair value suggests significant upside if turnaround occurs
  • Low beta indicates limited correlation to broader market swings
  • Potential for restructuring to improve balance‑sheet health

Key Metrics & Analysis

Financial Health

Revenue Growth4.20%
Profit Margin-0.66%
ROE-0.07%
ROA0.54%
Debt/Equity18.81
Op. Cash Flow₩38.4B
Free Cash Flow₩-8154677760

Technical Analysis

TrendBullish
RSI33.5
Support₩13,210.00
Resistance₩17,970.00
MA 20₩15,154.00
MA 50₩15,038.40
MA 200₩13,931.50
MACDBearish
VolumeStable
Fear & Greed Index93.21

Valuation

Fair Value₩31,169.93
GradeUndervalued
TypeValue
Dividend Yield1.81%

Risk Assessment

Beta0.37
Volatility49.51%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.